Journals / Klimik Dergisi / 2017 / Cilt: 30 - Sayı: 3

Nosocomial Meningitis Due to Multidrug-Resistant Acinetobacter baumannii Successfully Treated With Intrathecal Colistin

İntratekal Kolistinle Başarıyla Tedavi Edilen Çoğul Dirençli Acinetobacter baumannii’ye Bağlı Nozokomiyal Menenjit

Pages
61–63
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Cerebrospinal fluid examination of the patient improved after the addition of the intrathecal colistin to intravenous colistin and meropenem.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acinetobacter baumannii, a healthcare-associated infectious agent with various antibiotic resistance mechanisms, may cause pneumonia, meningitis and sepsis with severe course and high mortality rate.
📊
Key Findings & Data:In this article, 28-year-old male who had nosocomial meningitis following neurosurgical intervention was presented and the literature was reviewed.
💡
Conclusion & Impact:Cerebrospinal fluid examination of the patient improved after the addition of the intrathecal colistin to intravenous colistin and meropenem.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Acinetobacter baumannii, a healthcare-associated infectious agent with various antibiotic resistance mechanisms, may cause pneumonia, meningitis and sepsis with severe course and high mortality rate. Multidrug-resistant A. baumannii isolates are frequently responsible for post-neurosurgical nosocomial meningitis. In this article, 28-year-old male who had nosocomial meningitis following neurosurgical intervention was presented and the literature was reviewed. Cerebrospinal fluid examination of the patient improved after the addition of the intrathecal colistin to intravenous colistin and meropenem.

Özet

Acinetobacter baumannii çeşitli mekanizmalarla çoğul antibiyotik direnci gösterebilen, önemli bir sağlık bakımıyla ilişkili infeksiyon etkenidir. Pnömoni, menenjit ve sepsis gibi mortalite oranı yüksek, ciddi seyirli infeksiyonlara neden olabilir. Beyin cerrahisi girişimlerinden sonra görülen nozokomiyal menenjitlerin büyük bir kısmından çoğul ilaç dirençli A. baumannii suşları sorumludur. Bu yazıda, nöroşirürji girişimi sonrası çoğul ilaç direnci olan A. baumannii'ye bağlı olarak nozokomiyal menenjit gelişen, intravenöz kolistin ve meropenem tedavisine ek olarak intratekal kolistin uygulandıktan sonra beyin-omurilik sıvısı bulguları düzelen 28 yaşında bir erkek hasta sunularak literatür gözden geçirilmiştir.

🔖

Cite This Article

YILDIRIM, M., KINIKLI, S., ÇELİK, H., HATİPOĞLU, Ç. A., ÇERÇİOĞLU, D., CESUR, S., BAYAR, M. A. (2022). Nosocomial Meningitis Due to Multidrug-Resistant Acinetobacter baumannii Successfully Treated With Intrathecal Colistin. Klimik Dergisi, Cilt: 30 - Sayı: 3, 61–63. https://ajindex.com/articles/573563

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Ni S, Li S, Yang N, et al. Post-neurosurgical meningitis caused by acinetobacter baumannii: case series and review of the literature. Int J Clin Exp Med. 2015; 8(11): 21833-8
  2. Schiaroli E, Pasticci MB, Cassetta MI, et al. Management of meningitis caused by multi drug-resistant Acinetobacter baumannii: clinical, microbiological and pharmacokinetic results in a patient treated with colistin methanesulfonate. Mediterr J Hematol Infect Dis. 2015; 7(1): e2015055
  3. Rodríguez Guardado A, Blanco A, Asensi V, et al. Multidrugresistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother. 2008; 61(4): 908-13
  4. De Bonis P, Lofrese G, Scoppettuolo G, et al. Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis. Eur J Neurol. 2016; 23(1): 68-75
  5. Cesur S, Altın N, Yapar Toros G, et al. Beyin cerrahisi sonrası çok ilaca dirençli Acinetobacter baumannii’ye bağlı nozokomiyal menenjit gelişen olguda intratekal netilmisin tedavisi. Türk Mikrobiyol Cemiy Derg. 2011; 41(4):168-171
  6. Fotakopoulos G, Makris D, Chatzi M, Tsimitrea E, Zakynthinos E, Fountas K. Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin. Acta Neurochir (Wien). 2016; 158(3): 603-10; discussion 610
  7. Bargiacchi O, De Rosa FG. Intrathecal or intraventricular colistin: a review. Infez Med. 2016; 24(1): 3-11
  8. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004; 39(9): 1267-84
  9. Karaiskos I, Galani L, Baziaka F, Giamarellou H. Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agents. 2013; 41(6): 499-508
  10. Ho YH, Wang LS, Chao HJ, Chang KC, Su CF. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin. See comment in PubMed Commons below J Microbiol Immunol Infect. 2007; 40(6): 537-40
  11. Cascio A, Conti A, Sinardi L, et al. Post-neurosurgical multidrugresistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature. Int J Infect Dis. 2010; 14(7): e572-9. 12.